Annual Congress, European Society of Medical Oncology (ESMO)
DATE07/10/2016 - 11/10/2016
PLACECopenhagen, Denmark
Poly-therapy with EGFR, STAT3 and Src-YAP1 signaling pathway inhibition; A breakthrough for EGFR mutant NSCLC N. Karachaliou, I. Chaib, X. Cai, X. Li, A.F. Cardona, G. López-Vivanco, A. Vergnenegre, J.M. Sanchez Torres, M. Provencio, F. de Marinis, E. Carecereny, N. Reguart, R. García Campelo, S. Viteri, M.A. Molina Vila, C. Zhou, P. Cao, P.Ma, T. Bivona, R. Rosell Poster 1188P
[return]
Brigatinib (BRG) in patients (Pts) with anaplastic lymphoma kinase (ALK)–positive non–small cell lung cancer (NSCLC) in a phase 1/2 trial
L. Bazhenova, S. Gettinger, C. Langer, R. Salgia, K. Gold, R. Rosell, A. Shaw, G. Weiss, J. Haney, V. Rivera, F. Haluska, D. Kerstein, D. R. Camidge Poster 1207PD
Molecular analysis in serial biopsies in sinonasal mucosal melanoma
G. Anguera Palacios, M.Á. Molina-Vila, J.R. Gras-Cabrerizo, X. León, C. Mayo, J. Codony Servat, A. Pérez-Rosado, S. Rodríguez, M. González-Cao, N. Karachaliou, A. Barnadas, R. Rosell, M. Majem Poster 1005P
Automated nCounter-based assay for identifying clinically relevant ALK, ROS1 and RET rearrangements in advancednon-small cell lung cancer (NSCLC)
N. Reguart, L. Paré, A. Giménez-Capitán, C. Teixidó, P. Galván, S. Viteri, S. Rodríguez, V. Peg, E. Aldeguer, E. Ovalle, N. Viñolas, S. Merkelbach-Bruse, F. Lopez-Rios, R. Rosell, M.Á. Molina-Vila, A. Prat
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis
U. Malapelle, C. Mayo, D. Rocco, M. Garzon, P. Pisapia, R. Sgariglia, C. De Luca, N.J. Ariza, F. Pepe, D.M. Espinosa, A.M. Bueno, M. González-Cao, N. Karachaliou, S. Viteri, M.A. Molina Vila, R. Rosell, G. Troncone Poster 66P
Biomarker driven combinations for synthetic lethal approaches in KRAS mutant (KRASm) lung adenocarcinoma (LAC)
C. Lazzari, A. Verlicchi, C. Codony Servat, J. Codony Servat, M.A. Molina Vila, I. Chaib, J.L. Ramírez Serrano, N. Karachaliou, F. de Marinis, R. Rosell Poster 1526P
Differential expression profile of lung squamous cell carcinoma (LSCC) and druggable targets to be combined with necitumumab (N)
A. Verlicchi, C. Lazzari, C. Codony Servat, M.A. Molina Vila, J. Codony Servat, I. Chaib, J.L. Ramírez Serrano, N. Karachaliou, C. Dazzi, R. Rosell Poster 1527P